ECTRIMS 2021: COVID-19 Seroconversion Rates are Lower in Patients With MS Who Have Received Certain Disease-Modifying Therapies
Some drugs are linked to failure to develop a post-vaccination humoral response.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.